Banking on shared experiences — and now a big investor — with brother Vivek, Shankar Ramaswamy stacks up a $100M mega-round
Shankar Ramaswamy learned a lot when he went to work for his older brother Vivek at Axovant. He also gained some important relationships. And they are both coming into play as he takes his newly-founded gene therapy company up to the next level of R&D.
Earlier today Kriya Therapeutics rather quietly came out with the news that it has raised an even $100 million for its B round, just a little over a year after he and his crew snagged their $80 million launch round.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 113,300+ biopharma pros reading Endpoints daily — and it's free.